Helge Immo Lehmann, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ablation Techniques | 6 | 2020 | 249 | 1.430 |
Why?
|
Atrioventricular Node | 3 | 2020 | 182 | 1.210 |
Why?
|
Cardiac Resynchronization Therapy | 2 | 2023 | 532 | 1.130 |
Why?
|
Defibrillators, Implantable | 3 | 2023 | 1440 | 0.880 |
Why?
|
Arrhythmias, Cardiac | 5 | 2022 | 2267 | 0.610 |
Why?
|
Pacemaker, Artificial | 1 | 2023 | 817 | 0.590 |
Why?
|
Cryosurgery | 5 | 2021 | 453 | 0.570 |
Why?
|
Radiotherapy, High-Energy | 1 | 2016 | 228 | 0.560 |
Why?
|
Pulmonary Veins | 5 | 2021 | 759 | 0.530 |
Why?
|
Catheter Ablation | 8 | 2021 | 2746 | 0.480 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2018 | 2059 | 0.460 |
Why?
|
Photons | 1 | 2017 | 587 | 0.440 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2012 | 91 | 0.430 |
Why?
|
Sus scrofa | 4 | 2020 | 437 | 0.420 |
Why?
|
Myocytes, Cardiac | 6 | 2024 | 1636 | 0.380 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2017 | 806 | 0.370 |
Why?
|
Perfusion | 1 | 2015 | 1359 | 0.370 |
Why?
|
Myocardial Reperfusion Injury | 2 | 2023 | 476 | 0.350 |
Why?
|
Peptide Hydrolases | 1 | 2012 | 627 | 0.340 |
Why?
|
Renin-Angiotensin System | 1 | 2012 | 759 | 0.310 |
Why?
|
Arginine | 1 | 2011 | 944 | 0.300 |
Why?
|
Myocardium | 5 | 2021 | 4775 | 0.300 |
Why?
|
Heart Failure | 4 | 2024 | 10856 | 0.290 |
Why?
|
Tachycardia, Ventricular | 3 | 2020 | 1272 | 0.260 |
Why?
|
Electrophysiologic Techniques, Cardiac | 3 | 2018 | 489 | 0.260 |
Why?
|
Primary Prevention | 1 | 2012 | 1166 | 0.250 |
Why?
|
Models, Animal | 4 | 2020 | 2170 | 0.220 |
Why?
|
Heart Conduction System | 2 | 2020 | 1048 | 0.210 |
Why?
|
Dogs | 7 | 2021 | 3910 | 0.210 |
Why?
|
Atrial Fibrillation | 5 | 2021 | 5019 | 0.210 |
Why?
|
Four-Dimensional Computed Tomography | 3 | 2017 | 145 | 0.200 |
Why?
|
Remote Sensing Technology | 1 | 2023 | 90 | 0.200 |
Why?
|
Therapeutic Irrigation | 2 | 2020 | 300 | 0.200 |
Why?
|
Electrocardiography | 4 | 2020 | 6440 | 0.200 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2022 | 124 | 0.200 |
Why?
|
Heart | 4 | 2023 | 4462 | 0.190 |
Why?
|
Marfan Syndrome | 1 | 2022 | 240 | 0.180 |
Why?
|
Tachycardia, Ectopic Atrial | 1 | 2020 | 66 | 0.180 |
Why?
|
Muscular Atrophy | 1 | 2023 | 350 | 0.180 |
Why?
|
X-Ray Therapy | 1 | 2019 | 9 | 0.170 |
Why?
|
Heart Atria | 2 | 2016 | 1348 | 0.170 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 3 | 2017 | 1622 | 0.170 |
Why?
|
Purkinje Fibers | 1 | 2018 | 32 | 0.170 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2016 | 876 | 0.160 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2020 | 964 | 0.150 |
Why?
|
Electroporation | 1 | 2018 | 251 | 0.140 |
Why?
|
MicroRNAs | 2 | 2023 | 3731 | 0.140 |
Why?
|
Heart Rate | 3 | 2019 | 4091 | 0.140 |
Why?
|
Immobilization | 1 | 2017 | 236 | 0.140 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2017 | 143 | 0.140 |
Why?
|
Ventricular Fibrillation | 1 | 2018 | 538 | 0.130 |
Why?
|
Microbubbles | 1 | 2016 | 128 | 0.130 |
Why?
|
Freezing | 1 | 2015 | 303 | 0.120 |
Why?
|
Radiotherapy, Computer-Assisted | 1 | 2015 | 94 | 0.120 |
Why?
|
Intracranial Embolism | 1 | 2016 | 202 | 0.120 |
Why?
|
Animals | 19 | 2024 | 168561 | 0.120 |
Why?
|
Fiducial Markers | 1 | 2015 | 136 | 0.120 |
Why?
|
Carbon | 1 | 2017 | 686 | 0.110 |
Why?
|
Radiation Dosage | 2 | 2020 | 1927 | 0.110 |
Why?
|
Body Temperature | 1 | 2015 | 776 | 0.100 |
Why?
|
Radiotherapy Dosage | 2 | 2017 | 2876 | 0.100 |
Why?
|
Feasibility Studies | 3 | 2020 | 5062 | 0.100 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39004 | 0.090 |
Why?
|
Cardiomegaly | 2 | 2023 | 619 | 0.090 |
Why?
|
Patient Care Planning | 1 | 2016 | 921 | 0.090 |
Why?
|
Swine | 5 | 2019 | 5934 | 0.090 |
Why?
|
Positron-Emission Tomography | 2 | 2016 | 6259 | 0.090 |
Why?
|
Action Potentials | 1 | 2017 | 1814 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2016 | 2372 | 0.090 |
Why?
|
Equipment Design | 4 | 2020 | 3582 | 0.080 |
Why?
|
Apoptosis | 3 | 2024 | 9715 | 0.080 |
Why?
|
Needles | 2 | 2021 | 448 | 0.080 |
Why?
|
Heart Ventricles | 1 | 2020 | 3801 | 0.080 |
Why?
|
Aged, 80 and over | 3 | 2023 | 57683 | 0.070 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15108 | 0.070 |
Why?
|
Aging | 2 | 2022 | 8626 | 0.070 |
Why?
|
Enzyme Activation | 1 | 2012 | 3701 | 0.070 |
Why?
|
Exercise | 1 | 2022 | 5611 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2022 | 62966 | 0.070 |
Why?
|
Cohort Studies | 2 | 2023 | 40450 | 0.070 |
Why?
|
Humans | 20 | 2024 | 742088 | 0.070 |
Why?
|
Histones | 1 | 2015 | 2597 | 0.060 |
Why?
|
Male | 8 | 2023 | 349538 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2020 | 20086 | 0.060 |
Why?
|
Time Factors | 4 | 2020 | 40054 | 0.060 |
Why?
|
RNA, Messenger | 3 | 2022 | 13029 | 0.060 |
Why?
|
Ribose | 1 | 2022 | 68 | 0.050 |
Why?
|
Pandemics | 1 | 2023 | 8328 | 0.050 |
Why?
|
RNA | 2 | 2022 | 2747 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2011 | 2128 | 0.050 |
Why?
|
Female | 7 | 2023 | 379592 | 0.050 |
Why?
|
Quality of Life | 1 | 2022 | 12730 | 0.050 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2022 | 337 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2020 | 18006 | 0.050 |
Why?
|
Prospective Studies | 3 | 2018 | 53187 | 0.040 |
Why?
|
Aged | 3 | 2023 | 162944 | 0.040 |
Why?
|
Methyltransferases | 1 | 2022 | 367 | 0.040 |
Why?
|
Radiation, Nonionizing | 1 | 2019 | 6 | 0.040 |
Why?
|
Middle Aged | 4 | 2023 | 213127 | 0.040 |
Why?
|
Heavy Ions | 1 | 2019 | 12 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2020 | 11690 | 0.040 |
Why?
|
Echocardiography | 2 | 2021 | 5097 | 0.040 |
Why?
|
Troponin | 1 | 2022 | 524 | 0.040 |
Why?
|
Physical Fitness | 1 | 2022 | 732 | 0.040 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2022 | 686 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2023 | 814 | 0.040 |
Why?
|
Adenosine | 1 | 2022 | 823 | 0.040 |
Why?
|
Troponin T | 1 | 2022 | 749 | 0.040 |
Why?
|
Doxorubicin | 1 | 2024 | 2215 | 0.040 |
Why?
|
Pericardium | 1 | 2021 | 667 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2019 | 535 | 0.040 |
Why?
|
Necrosis | 1 | 2020 | 1643 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2023 | 1224 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 2006 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2022 | 1504 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2022 | 904 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2011 | 15056 | 0.030 |
Why?
|
Regeneration | 1 | 2023 | 1485 | 0.030 |
Why?
|
Brugada Syndrome | 1 | 2015 | 97 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2022 | 2440 | 0.030 |
Why?
|
Mice | 3 | 2024 | 81045 | 0.030 |
Why?
|
Catheters | 1 | 2015 | 422 | 0.030 |
Why?
|
Pulmonary Circulation | 1 | 2014 | 739 | 0.030 |
Why?
|
Fibroblasts | 1 | 2022 | 4143 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1780 | 0.020 |
Why?
|
Adult | 3 | 2023 | 213712 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2014 | 1525 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2023 | 3455 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2014 | 1423 | 0.020 |
Why?
|
Mitochondria | 1 | 2023 | 3520 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8333 | 0.020 |
Why?
|
Radiosurgery | 1 | 2019 | 1309 | 0.020 |
Why?
|
Risk Factors | 2 | 2016 | 72145 | 0.020 |
Why?
|
Temperature | 1 | 2014 | 2207 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7167 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2023 | 10472 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2023 | 9639 | 0.020 |
Why?
|
Stroke Volume | 1 | 2018 | 4983 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2011 | 77098 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8297 | 0.010 |
Why?
|